Stonepine Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-188,703
| Closed | -$557K | – | 30 |
|
|
2020
Q4 | $557K | Sell |
188,703
-400,794
| -68% | -$1.18M | 0.43% | 21 |
|
|
2020
Q3 | $1.89M | Sell |
589,497
-87,095
| -13% | -$280K | 1.97% | 13 |
|
|
2020
Q2 | $2.25M | Sell |
676,592
-231,143
| -25% | -$770K | 4.36% | 9 |
|
|
2020
Q1 | $3.3M | Buy |
907,735
+11,565
| +1% | +$42K | 3.48% | 14 |
|
|
2019
Q4 | $4.62M | Buy |
896,170
+35,721
| +4% | +$184K | 3.22% | 12 |
|
|
2019
Q3 | $5.1M | Sell |
860,449
-11,313
| -1% | -$67.1K | 4.95% | 6 |
|
|
2019
Q2 | $5.55M | Sell |
871,762
-330,213
| -27% | -$2.1M | 3.82% | 9 |
|
|
2019
Q1 | $6.98M | Sell |
1,201,975
-111,454
| -8% | -$648K | 4.02% | 9 |
|
|
2018
Q4 | $7.92M | Buy |
1,313,429
+95,028
| +8% | +$573K | 6.96% | 4 |
|
|
2018
Q3 | $6.96M | Buy |
1,218,401
+15,062
| +1% | +$86K | 4.07% | 9 |
|
|
2018
Q2 | $7.38M | Sell |
1,203,339
-119,702
| -9% | -$734K | 4.48% | 7 |
|
|
2018
Q1 | $8.84M | Buy |
1,323,041
+16,130
| +1% | +$108K | 4.74% | 7 |
|
|
2017
Q4 | $9.62M | Buy |
1,306,911
+34,720
| +3% | +$256K | 5.77% | 8 |
|
|
2017
Q3 | $8.98M | Buy |
1,272,191
+163,024
| +15% | +$1.15M | 5.29% | 11 |
|
|
2017
Q2 | $7.76M | Buy |
1,109,167
+369,250
| +50% | +$2.58M | 4.19% | 10 |
|
|
2017
Q1 | $5.14M | Buy |
739,917
+120,379
| +19% | +$835K | 2.89% | 14 |
|
|
2016
Q4 | $3.41M | Buy |
619,538
+295,791
| +91% | +$1.63M | 2.03% | 15 |
|
|
2016
Q3 | $1.62M | Buy |
323,747
+194,949
| +151% | +$977K | 1.32% | 12 |
|
|
2016
Q2 | $580K | Buy |
+128,798
| New | +$580K | 0.59% | 21 |
|